Laser Treatment for Twin-to-Twin Transfusion Syndrome
Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome
- Sex
- Female
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- Seattle Children's Hospital · Other
This trial is looking for pregnant women with twin-to-twin transfusion syndrome. Participants will receive laser treatment to improve outcomes for both twins.
You may be able to join if
- I have a single placenta.
- I have polyhydramnios in the recipient twin.
- I have oligohydramnios in the donor twin.
- I have a prominent bladder in the recipient twin.
- I have a thin dividing membrane.
You may not be able to join if
- I am unwilling to participate in the study.
- I have major congenital anomalies that are not compatible with survival.
- I am in active pre-term labor.
- I have ruptured membranes.
- I have chorioamnionitis.
- I am experiencing vaginal bleeding.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe purpose of this study is to evaluate the use of diode laser photocoagulation of the communicating vessels in twin-to- twin transfusion syndrome (TTTS) with respect to maternal, fetal and neonatal outcomes.
Loading trial locations…